Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Efficacy of Repeat, Monthly Treatments of Cutaneous Neurofibromas (cNFs)

NCT06300502 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT06300502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06300502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Efficacy of Repeat, Monthly Treatments of Cutaneous Neurofibromas (cNFs)
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1
Overall status
Enrolling by invitation
Start date
April 8, 2025
Completion date
February 28, 2027
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neurofibromas, cutaneous, neurofibromatosis 1